Marco Stellato

15PUBLICATIONS
40CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInnate immunityCancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 10, 2026
Local treatment of the primary tumor in mHSPC in the ARPI era: incremental value or overtreatment?

|May 06, 2026
177Lu-PSMA-617 radioligand therapy as an immune modulator in prostate cancer.

|Jan 10, 2026
An update on the treatment paradigm for non-clear cell renal cell carcinoma.

Alessandro Rametta, Noemi Crippa, Simone Rota

|Aug 29, 2025
Medication-related jaw osteonecrosis in metastatic RCC treated with VEGFR-TKIs ± IO and bone agents: A real-world analysis.

Marco Stellato, Ernesto Zecca, Paola Bracchi

|Oct 19, 2023
Navigating the Rapidly Evolving Advanced Urothelial Carcinoma Treatment Landscape: Insights from Italian Experts.

Daniele Santini, Giuseppe Luigi Banna, Sebastiano Buti

|Jul 26, 2023
The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study.

Chiara Tommasi, Giulia Scartabellati, Diana Giannarelli

Pageof 3

Frequent Collaborators

5 joint publications

Sebastiano Buti

4 joint publications

Alessandro Rametta

4 joint publications

Giuseppe Procopio

3 joint publications

Giuseppe Luigi Banna